Overview
What is Care Collaborative Action For Sar2 Cov2 Eradicatio?
Care Collaborative Action for Sar2 Cov2 Eradication is a nonprofit organization dedicated to assisting Covid-19 patients. They carry out this mission through various programs and services. One of their projects involves providing relief and rehabilitation for the indigenous community in the Indore-Ujjain region of India, affected by the pandemic. Furthermore, they have contributed oxygen concentrators to hospitals in India as part of their Covid relief efforts. In essence, Care Collaborative Action for Sar2 Cov2 Eradication is committed to supporting those impacted by the virus, offering aid and resources where needed.
Is Care Collaborative Action For Sar2 Cov2 Eradicatio legitimate?
Care Collaborative Action For Sar2 Cov2 Eradicatio is a legitimate nonprofit organization registered as a 501(c)(3) entity. Care Collaborative Action For Sar2 Cov2 Eradicatio submitted a form 990EZ, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
What is the mission statement of Care Collaborative Action For Sar2 Cov2 Eradicatio?
Care Collaborative Action for Sar2 Cov2 Eradication's mission is focused on aiding Covid-19 patients. They aim to accomplish this through various programs and services. Notably, they funded projects providing relief and rehabilitation for the indigenous community in the Indore-Ujjain region of India during the pandemic. Furthermore, they contributed oxygen concentrators to hospitals in India as part of their Covid relief efforts. In essence, their mission is to support and assist individuals affected by Covid-19.
Who is the CEO of Care Collaborative Action For Sar2 Cov2 Eradicatio?
Sunil Chaturvedi is the CEO of Care Collaborative Action For Sar2 Cov2 Eradicatio The CEO's salary of Care Collaborative Action For Sar2 Cov2 Eradicatio is $0 and their total compensation is $0.
What is the revenue of Care Collaborative Action For Sar2 Cov2 Eradicatio?
Care Collaborative Action For Sar2 Cov2 Eradicatio's revenue in 2022 was $0.
Who are the executives of Care Collaborative Action For Sar2 Cov2 Eradicatio and what are their salaries?
Here are 5 key members and their salaries (Care Collaborative Action For Sar2 Cov2 Eradicatio's CEO's salary is $0 and their total compensation is $0):
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Where can I find the form 990EZ for Care Collaborative Action For Sar2 Cov2 Eradicatio?
Care Collaborative Action For Sar2 Cov2 Eradicatio's most recent form 990EZ was submitted in 2022 and can be accessed here.
Mission Statement of Care Collaborative Action For Sar2 Cov2 Eradicatio
Care Collaborative Action for Sar2 Cov2 Eradication is an organization dedicated to assisting Covid-19 patients through various programs and services. Their mission, in essence, is to provide relief and rehabilitation projects related to the coronavirus pandemic, with a specific focus on the indigenous community residing in the Indore-Ujjain region of India. Moreover, they have funded projects aimed at addressing the Covid-19 crisis and have donated oxygen concentrators to hospitals within India as part of their Covid relief efforts.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
Care Collaborative Action for Sar2 Cov2 Eradication has made a significant impact in addressing the challenges posed by Covid-19, particularly in the indigenous communities of the Indore-Ujjain region of India. By funding relief and rehabilitation projects, they have directly assisted Covid-19 patients through various programs and services tailored to meet their needs.
One of the focal points of their efforts has been the provision of vital medical equipment, such as oxygen concentrators, to hospitals in India. This initiative has been crucial in supporting healthcare facilities struggling to manage the influx of Covid-19 patients requiring respiratory assistance. The distribution of these concentrators has not only enhanced the capacity of local hospitals but has also improved patient outcomes by ensuring timely access to crucial treatment.
Their work emphasizes the importance of targeted interventions in underserved communities, where access to healthcare resources can be limited. By focusing on relief efforts in these areas, Care Collaborative Action for Sar2 Cov2 Eradication has played a pivotal role in mitigating the impact of the pandemic, fostering resilience, and ensuring that vulnerable populations receive the necessary care and support during one of the most challenging times in recent history.
This information is meant to be a general summary of Care Collaborative Action For Sar2 Cov2 Eradicatio. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
Assets and Liabilities:
- Total Assets: $22,337
- Total Liabilities: $0
- Net Assets: $22,337
Want to help this charity, for free? You can click here to learn more about Give Freely
Organization Details
Principal Officer
Sunil Chaturvedi
NTEE Category
Code: H80 - Medical research
If you are a representative of Care Collaborative Action For Sar2 Cov2 Eradicatio and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.